দেশ: নিউ জিলণ্ড
ভাষা: ইংরেজি
সূত্র: Medsafe (Medicines Safety Authority)
Ropinirole hydrochloride 2.28mg equivalent to to 2 mg ropinirole
Apotex NZ Ltd
Ropinirole hydrochloride 2.28 mg (= to 2 mg ropinirole)
2 mg
Film coated tablet
Active: Ropinirole hydrochloride 2.28mg equivalent to to 2 mg ropinirole Excipient: Citric acid Hyprolose Hypromellose Iron oxide red Lactose Macrogol 8000 Magnesium stearate Titanium dioxide
Blister pack, Al foil/ Al foil laminate, 84 tablets
Prescription
Prescription
Ind-Swift Laboratories Limited
Ropinirole is indicated for the treatment of Parkinson's disease. Ropinirole is effective as early therapy in patients requiring dopaminergic therapy. In a comparative study, ropinirole was superior to bromocriptine. When these two drugs were administered concomitantly with selegiline there was no difference between them. Ropinirole delays the need for initiation of L-dopa therapy. As adjunctive treatment of L-dopa, ropinirole enhances the efficacy of L-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic L-dopa therapy and permits reduction in daily L-dopa dose.
Package - Contents - Shelf Life: Blister pack, Al foil/ Al foil laminate - 84 tablets - 24 months unopened stored at or below 25°C protect from light and moisture - Blister pack, Al foil/ Al foil laminate - 100 tablets - 24 months unopened stored at or below 25°C protect from light and moisture - Bottle, plastic, HDPE bottle with blue HDPE cap and silica/activated carbon desiccant - 84 tablets - 24 months unopened stored at or below 25°C protect from light and moisture 84 days opened stored at or below 25°C protect from light and moisture - Bottle, plastic, HDPE bottle with blue HDPE cap and silica/activated carbon desiccant - 100 tablets - 24 months unopened stored at or below 25°C protect from light and moisture 84 days opened stored at or below 25°C protect from light and moisture
2009-11-27
NEW ZEALAND DATA SHEET APO-ROPINIROLE Please refer to Medsafe website (www.medsafe.govt.nz) for the most recent datasheet Page 1 of 7 1. PRODUCT NAME APO-ROPINIROLE 0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg and 5mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Ropinirole hydrochloride 0.25mg Ropinirole hydrochloride 0.5mg Ropinirole hydrochloride 1mg Ropinirole hydrochloride 2mg Ropinirole hydrochloride 3mg Ropinirole hydrochloride 4mg Ropinirole hydrochloride 5mg EXCIPIENT(S) WITH KNOWN EFFECT Contains lactose. For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM APO-ROPINIROLE is available as oral, film coated tablets in the following strengths: APO-ROPINIROLE 0.25mg tablets are white, pentagonal, biconvex film-coated tablet identified by an engraved “ROP” over “.25” on one side and “APO’ on the other side. Each tablet typically weighs about 153mg. APO-ROPINIROLE 0.5mg tablets are yellow, pentagonal, biconvex film-coated tablet identified by an engraved “ROP” over “.5” on one side and “APO’ on the other side. Each tablet typically weighs about 153mg. APO-ROPINIROLE 1mg tablets are green, pentagonal, biconvex film-coated tablet identified by an engraved “ROP” over “1” on one side and “APO’ on the other side. Each tablet typically weighs about 153mg. APO-ROPINIROLE 2mg tablets are pink, pentagonal, biconvex film-coated tablet identified by an engraved “ROP” over “2” on one side and “APO’ on the other side. Each tablet typically weighs about 153mg. APO-ROPINIROLE 3mg tablets are purple, pentagonal, biconvex film-coated tablet identified by an engraved “ROP” over “3” on one side and “APO’ on the other side. Each tablet typically weighs about 153mg. APO-ROPINIROLE 4mg tablets are pale brown, pentagonal, biconvex film-coated tablet identified by an engraved “ROP” over “4” on one side and “APO’ on the other side. Each tablet typically weighs about 153mg. APO-ROPINIROLE 5mg tablets are blue, pentagonal, biconvex film-coated tablet সম্পূর্ণ নথি পড়ুন